Characterization of a Murine Model System to Study MicroRNA-147 During Inflammatory Organ Injury

Boyun Kim1, Victor Guaregua1, Xuebo Chen1

  • 1Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA.

Inflammation
|February 10, 2021
PubMed

Insights

Researchers developed a new transgenic mouse model to study microRNA-147 (miR-147) in inflammatory conditions. This model allows for targeted gene deletion, aiding the investigation of miR-147

Area of Science:

  • Molecular Biology
  • Genetics
  • Immunology
  • Critical Care Medicine

Background:

  • Inflammatory organ injury and sepsis significantly impact surgical and critical care patient outcomes.
  • MicroRNAs (miRNAs), including microRNA-147 (miR-147), are key regulators of gene expression with roles in inflammation.
  • A lack of in vivo animal models hinders the study of tissue-specific miR-147 functions during inflammation.

Purpose of the Study:

  • To characterize miR-147 expression across various organs and cell types.
  • To develop a transgenic mouse model for studying tissue-specific miR-147 deletion in inflammatory conditions.
  • To investigate the baseline and inflammation-induced effects of miR-147 deletion in vivo.

Main Methods:

  • Expression profiling of miR-147 in different organs and cell types.
  • Generation of a floxed miR-147 transgenic mouse line.
  • Creation of whole-body miR-147 knockout mice (miR-147-/-) using CMVcre recombination.
  • Assessment of miR-147 deletion efficacy in various tissues under baseline and inflammatory states.
  • Comparative analysis of baseline inflammatory gene expression between miR-147-/- and wild-type mice.

Main Results:

  • miR-147-/- mice exhibited normal growth, development, and reproductive capacity.
  • Successful deletion of miR-147 was confirmed in multiple organs (heart, intestine, liver, spleen, lungs, kidneys) at baseline and during inflammation.
  • Baseline inflammatory gene expression was largely similar to wild-type mice, with a notable exception of elevated IL-6 in the spleen of miR-147-/- mice.

Conclusions:

  • A novel transgenic mouse model enabling tissue-specific deletion of miR-147 has been successfully developed.
  • This model provides a valuable tool for dissecting the functional roles of miR-147 in inflammatory organ injury.
  • The findings lay the groundwork for future research into miR-147's specific contributions to inflammatory processes in vivo.

Related Concept Videos